Non-absorbed rifamycin antibiotic
This page covers all Non-absorbed rifamycin antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial RNA polymerase.
Targets
Marketed (1)
- Rifaximin (XIFAXAN) · University of California, San Francisco · Gastroenterology / Infectious Disease
Rifaximin is a non-absorbed antibiotic that inhibits bacterial RNA polymerase to reduce pathogenic gut bacteria without systemic absorption.
Patent intelligence
- non absorbed rifamycin antibiotic patent landscape — aggregated cliff calendar, attackable patents, originator estates